Sai Life Sciences Limited

SAILIFE

INE570L01029

Pharmaceuticals

End-of-day quote NSE India S.E. Other stock markets 14/01/2026			5-day change	1st Jan Change
905.30 ^INR	+0.06%		-6.40%	-0.34%

31/12	Sai Life Sciences receives tax penalty of 49.3 million rupees	RE
11/12	Sai Life Sciences receives tax penalty of 32.6 million rupees	RE

Sai Life Sciences gets tax penalty of 9.28 million

Published on 12/08/2025 at 04:11 pm IST

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Sai Life Sciences Limited

31/12	Sai Life Sciences receives tax penalty of 49.3 million rupees	RE
11/12	Sai Life Sciences receives tax penalty of 32.6 million rupees	RE
08/12	Sai Life Sciences gets tax penalty of 9.28 million	RE
20/11	Sai Life Sciences gets tax demand for 208.5 million rupees, interest 137.5 million rupees, penalty 20.8 million rupees	RE
19/11	Sai Life Sciences Limited, Q2 2026 Earnings Call, Nov 07, 2025
11/11	Sai Life Sciences to recruit 200 scientists in November 2025	RE
07/11	Indian drugmaker Divi's beats profit view for second quarter on API boost	RE
06/11	Sai Life Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
06/11	Sai Life Sciences Sept-quarter consol profit 838.4 million rupees	RE
27/25/27	Sai Life Sciences Limited Set to Double Process R&D Capacity with New Facility in Hyderabad	CI
27/25/27	Sai Life Sciences Begins Construction of New Process R&D Centre in Hyderabad, India	MT
08/25/08	Sai Life Sciences announces integrated CMC partnership	RE
08/25/08	Sai Life Sciences Limited, Agility Life Sciences and Centrix Pharma Solutions Announces the Launch of an Integrated CMC Partnership Aimed at Accelerate Drug Development for Innovators	CI
18/25/18	Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India	CI
18/25/18	Sai Life Sciences opens dedicated facility for veterinary API production, in Bidar	RE
18/25/18	Sai Life Sciences Opens Veterinary API Facility in Karnataka	MT
28/25/28	Sai Life Sciences Completes Second Phase of New Production Unit in Bidar, India; Shares Up 5%	MT
28/25/28	Sai Life Sciences Limited Completes Phase II of Production Block 11 At Bidar, India, Expands Capacity to 700 KL	CI
26/25/26	Tpg sells 30.7 million shares of Sai Life Sciences in bulk deals	RE
26/25/26	INDIA STOCKS-Indian shares slide on US tariff worries, erase August gains	RE
08/25/08	Sai Life Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
27/25/27	1,960,000 Equity Shares of Sai Life Sciences Limited are subject to a Lock-Up Agreement Ending on 27-JUN-2025.	CI
23/25/23	Sai Life Sciences Limited(BSE:544306) added to S&P Global BMI Index	CI
20/25/20	TPG Reportedly to Sell 6% Stake in Sai Life Sciences at Estimated Price of $102 Million in Block Deal	CI
20/25/20	Sai Life Sciences Has Begun Commercial Operations of Second Phase of Bidar, India Unit Expansion	MT

Chart Sai Life Sciences Limited

Duration

Period

SAILIFE: Dynamic Chart

Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.

Employees

3,401

Sector

Pharmaceuticals

Calendar

05/02 - Q3 2026 Earnings Release (Projected)

More about the company